Agilis Robotics develops highly miniaturized and flexible robotic instruments for endoluminal surgery. These ultra-thin instruments, with diameters between 2.8 mm and 3.5 mm, enable surgeons to access and remove tumors deep within the urinary and gastrointestinal tracts without external incisions. The system offers enhanced dexterity and seamless integration with standard clinical endoscopes to improve surgical efficiency and patient recovery.
Funding
$17.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current endoscopic surgical methods often lack the dexterity and precision required for effective en-bloc resection of tumors, particularly in hard-to-reach areas of the urinary and gastrointestinal tracts. Traditional laparoscopic approaches, while offering better control, are more invasive, leading to increased patient trauma and longer recovery times. The learning curve for complex endoscopic procedures can also limit widespread adoption and effectiveness.
Solution
Agilis Robotics develops ultra-thin, flexible robotic instruments designed to enhance surgical capabilities in endoluminal procedures. Their system allows surgeons to access and remove tumors in the urinary and gastrointestinal tracts through natural body openings, eliminating the need for external incisions. The miniaturized robotic arms provide enhanced dexterity and intuitive control, facilitating precise en-bloc resection. This approach aims to improve surgical efficiency, reduce patient trauma, and enable faster recovery compared to traditional methods. The system's design ensures seamless integration with standard clinical endoscopes, reducing the learning curve and minimizing disruption to existing workflows.
Target Audience
The primary target audience includes surgeons specializing in urology and gastroenterology who seek to improve the precision and efficiency of minimally invasive endoluminal surgeries.
Features
- Ultra-thin, fully flexible instruments with diameters ranging from 2.8 mm to 3.5 mm and lengths up to 1.8 m
- Two highly dextrous and intuitive robotic arms for enhanced surgical precision
- Compatibility with standard clinical endoscopes for seamless integration
- Capability for both flexible and rigid endoluminal procedures within a single robotic system
- Designed to facilitate en-bloc resection of tumors in the upper and lower GI tract (ESD) and urinary tract (ERBT)
- Single-use instruments to maintain sterility and reduce the risk of cross-contamination